HealthEquity, Inc. (HQY) has been gaining from its business model and strategy. The optimism led by a solid second-quarter fiscal 2025 performance and strength in Health Savings Accounts (HSA) are expected to contribute further. However, data security issues and macro challenges are major downsides. Over the past six months, this Zacks Rank #2 (Buy) stock has gained 0.3% against the industry's 2.5% decline and the S&P 500's 10.2% rise. The renowned provider of technology-enabled services platforms for healt ...

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all. In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end. However, it's pretty easy to find cutting-edge growth stocks with the help of the Zacks Growth Style Sco ...

HealthEquity (HQY) closed the last trading session at $78.80, gaining 3.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $104.71 indicates a 32.9% upside potential. The mean estimate comprises 14 short-term price targets with a standard deviation of $5.22. While the lowest estimate of $95 indicates a 20.6% increase from the current price level, the most optimistic analyst expects ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens. Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style Score ...

Investors interested in stocks from the Medical Services sector have probably already heard of HealthEquity (HQY) and Medpace (MEDP) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Sty ...

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth stock that can live up to its true potential can be a tough task. In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end. However, it's pretty easy to find cutting-edge growth stocks w ...

HealthEquity (HQY) closed the last trading session at $76.24, gaining 7.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $104.14 indicates a 36.6% upside potential. The average comprises 14 short-term price targets ranging from a low of $92 to a high of $115, with a standard deviation of $6.14. While the lowest estimate indicates an increase of 20.7% from the current price level, ...

HealthEquity (HQY) recently announced a new collaboration with Paytient, a healthcare technology firm, to offer working professionals greater confidence in pursuing healthcare through Health Payment Accounts (HPAs). This new partnership is likely to enhance working professionals' access to healthcare. HPAs offer a no-interest, no-fee option for employees to pursue medical care with flexible payment terms. As a result of the partnership, a lot of employees are likely to onboard HQY's platform where they can ...

HealthEquity, Inc. (HQY) reported adjusted earnings per share (EPS) of 86 cents for second-quarter fiscal 2025, surpassing the Zacks Consensus Estimate by 22.9%. The bottom line improved 62.2% on a year-overyear basis. GAAP EPS in the fiscal second quarter was 40 cents, up 233% from the year-ago quarter's EPS of 12 cents. Shares of HQY were up 0.2% in after-market trading following the earnings call. HealthEquity Revenues in Detail In the fiscal second quarter, the company generated revenues of $299.93 mill ...

HealthEquity, Inc. (NASDAQ:HQY) Q2 2025 Earnings Conference Call September 3, 2024 4:30 PM ET Company Participants Richard Putnam - IR Jon Kessler - President & CEO James Lucania - EVP & CFO Steve Neeleman - Vice Chair and Founder Conference Call Participants Anne Samuel - J.P. Morgan Glen Santangelo - Jefferies Sean Dodge - RBC Capital Markets Stan Berenshteyn - Wells Fargo Securities Allen Lutz - Bank of America Scott Schoenhaus - KeyBanc David Larsen - BTIG Stephanie Davis - Barclays Mark Marcon - Baird ...